One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...
A federal judge ruled Friday that the Department of Education violated the First Amendment rights of some agency employees ...
In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
CBS News' "60 Minutes" gave its audience a rare opportunity by releasing a full, unedited video and transcript of its ...
Nex-z is the most closely watched drug in Intellia’s development pipeline. The company said in September that it planned to ...
The rise of artificial intelligence has produced serial writers to science and medical journals, most likely using chatbots to boost the number of citations they’ve published.